Literature DB >> 7529253

Evaluation of third-generation assays for detection of anti-hepatitis C virus (HCV) antibodies and comparison with presence of HCV RNA in blood donors reactive to c100-3 antigen.

D Lavanchy1, C Mayerat, B Morel, P Schneider, C Zufferey, J J Gonvers, A Pécoud, P C Frei.   

Abstract

We tested serum samples from blood donors by using first-, second-, and third-generation enzyme immunoassays or recombinant immunoblot assays. Second- and third-generation assays gave comparable results. Circulating hepatitis C virus RNA was found in a high proportion of reactive samples. A lack of reactivity or low-level reactivity predicted the absence of hepatitis C virus RNA in 100% of the cases.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7529253      PMCID： PMC263981          DOI： 10.1128/jcm.32.9.2272-2275.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  23 in total

1.  Reactivity to c33c antigen as a marker of hepatitis C virus multiplication.

Authors:  M Martinot-Peignoux; P Marcellin; L Z Xu; J Bernuau; S Erlinger; J P Benhamou; D Larzul
Journal:  J Infect Dis       Date:  1992-03       Impact factor: 5.226

2.  HCV RNA in serum of asymptomatic blood donors involved in post-transfusion hepatitis (PTH).

Authors:  E Villa; I Ferretti; M De Palma; M Melegari; P P Scaglioni; P Trande; C Vecchi; N Fratti; F Manenti
Journal:  J Hepatol       Date:  1991-09       Impact factor: 25.083

3.  Second-generation RIBA to confirm diagnosis of HCV infection.

Authors: 
Journal:  Lancet       Date:  1991-04-13       Impact factor: 79.321

4.  Evaluation of first- and second-generation RIBA kits for detection of antibody to hepatitis C virus.

Authors:  R K Chaudhary; C MacLean
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

5.  Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays.

Authors:  A Widell; A S Månsson; G Sundström; B G Hansson; E Nordenfelt
Journal:  J Med Virol       Date:  1991-12       Impact factor: 2.327

6.  Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase.

Authors:  P P Ulrich; J M Romeo; P K Lane; I Kelly; L J Daniel; G N Vyas
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

7.  Anti-HCV in post-transfusion hepatitis: deductions from a prospective study.

Authors:  S V Feinman; B Berris; R Herst
Journal:  J Hepatol       Date:  1991-05       Impact factor: 25.083

8.  Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein.

Authors:  B Hosein; C T Fang; M A Popovsky; J Ye; M Zhang; C Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

9.  Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.

Authors:  J M Barrera; M Bruguera; M G Ercilla; J M Sánchez-Tapias; M P Gil; J Costa; A Gelabert; J Rodés; R Castillo
Journal:  Ann Intern Med       Date:  1991-10-15       Impact factor: 25.391

10.  Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users.

Authors:  P Simmonds; L Q Zhang; H G Watson; S Rebus; E D Ferguson; P Balfe; G H Leadbetter; P L Yap; J F Peutherer; C A Ludlam
Journal:  Lancet       Date:  1990-12-15       Impact factor: 79.321
View more
  1 in total

Review 1.  Prevalence of hepatitis C virus in Brazil's inmate population: a systematic review.

Authors:  Mariana Cavalheiro Magri; Karim Yaqub Ibrahim; Walkyria Pereira Pinto; Francisco Oscar de Siqueira França; Wanderley Marques Bernardo; Fátima Mitiko Tengan
Journal:  Rev Saude Publica       Date:  2015-07-31       Impact factor: 2.106
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.